Conventional type of vaccines rely on either attenuated or dead virus, no? So with those examples, the external shape of the virus is what is supposed to inform the immune system; if I remember correctly. And I am of the understanding that these family of viruses have a good ability to change or adapt, so that any vaccine (presumably of any type) would merely trigger adaptation, especially in pandemic/endemic conditions due to high viral populations and therefore increased likelihood of advantageous mutation emerging.

In any case, you're right, it is definitely not worth it considering the current variants and the presence of other effective treatments.

Reply to this note

Please Login to reply.

Discussion

You are incorrect that this single stranded rna virus is known for being highly adaptable. It’s very slowly adapting because it’s genetic code is literally one big long run-on sentence. Defeating this is easy: target 6 or 8 viral proteins (or so…the actual number isn’t that important, just need “many”) but that’s 6-8 times harder than a vaccine against a single protein.

Influenza is a paged genome, meaning you can mix and match different influenza pages and create a nearly infinite number of new strains quite easily. That’s why we don’t have a vaccine for “influenza” but rather for specific strains.